Dr Reddy's Labs shares in focus after Q2 profit falls 15% YoY. What should investors do?
Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While ...
From Hyundai To LIC To Paytm; A Look At India's Mega IPOs With High Hopes & Low Returns Ahead Of Swiggy
The Indian primary market is heating up with the much-awaited initial public offering (IPO) of Swiggy Ltd, which is set to ...